ArticleMedicine2019

A case report of a dramatic response to olaparib in a patient with metastatic pancreatic cancer harboring a germline BRCA2 mutation.

Huan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.